Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible company

The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships

Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit.  Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.

Conflict of Interest

Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation. 

Speakers / Moderators / Discussants / Authors

Jill Dietz, MD, MHCM, FACS - Peace Medical Consulting LLC, Director/Moderated for TransAtlantic breast Cancer collaborative Conference, November, 2022, received fee

Denise M. Mammolito, MD, FACS - (Nothing to disclose)

Katharine Yao, MD, FACS - (Nothing to disclose)

Richard J. Bleicher, MD, FACS - Elucent Medical, Consultant/Speaker, received honorarium

Toan T. Nguyen, MD, FACS - Aptitude Health, Consultant, received fee

Richard Reitherman, MD, PhD  (Nothing to disclose)

Randy Stevens, MD - (Nothing to disclose)

Lee Gravatt Wilke, MD, FACS  Elucent Medical, Company founder, minority stock owner; Perimeter, PI of Clinical trial, Institutional Support for Clinical Trial

Paul Jeffers - (Nothing to disclose)

Judy Boughey, MBBCh, FACS   Peerview, Speaker, received honorarium

Virginia Schaffer, MD, FACS - (Nothing to disclose)

Kimberly Yee, MD, FACS - (Nothing to disclose)

Mediget Teshome, MD, FACS Endonaf, Conference attendance, received travel/accommodation

Timothy Vreeland, MD, FACS  LumaBridge, Designed clinical trial, received consulting fee

Planning Committee / Editorial Committee 

Rebecca Snyder, MD, FACS  (Nothing to disclose)

Alexander Olawaiye, MD, FACS - AstraZeneca, GSK, Clovis Scientific Advisory Board Meeting, received honorarium

Thomas Baker, MD (Nothing to disclose)

Laurie Kirstein, MD, FACS  (Nothing to disclose)

Bruce Brenner, MD, FACS  (Nothing to disclose)

Mehra Golshan, MD, FACS  Bertis, Scientific Advisor, received honorarium

Denise Mammolito, MD, FACS  (Nothing to disclose)

Judy Boughey, MBBCh, FACS  Peerview, speaker, honorarium    

Virginia Shaffer, MD, FACS (Nothing to disclose)    

Kimberly Yee, MD, FACS (Nothing to disclose)

Mediget Teshome, MD, FACS Endonaf travel, attendee, accomendation    

Timothy Vreeland, MD, FACS LumaBridge, designing clinical trial, consulting fee    

M. Asa Carter  (Nothing to disclose)

Chantel Ellis  (Nothing to disclose)

Alexander Barton  (Nothing to disclose)

Amanda Francescatti  (Nothing to disclose)

Eileen Riley (Nothing to disclose)

Clarissa Orr (Nothing to disclose)